Optometrists in Lamoni, IA Accepting Medicare
1 Optometrists found. Showing 1 - 1
 Dr Zieger Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1332 E Main St, Lamoni, IA 50140 Phone: 641-784-3737 Fax: 641-784-3911 |
News Archive
Scrumpox - deadly rugby virus spreads in sumo wrestlers
Rugby players may get more than just the ball out of a scrum - herpes virus can cause a skin disease called "scrumpox" and it spreads through physical contact. Researchers have studied the spread of the disease among sumo wrestlers in Japan and have discovered that a new strain of the virus could be even more pathogenic, according to an article published in the October issue of the Journal of General Virology.
The Obama health summit: More reactions, details emerge
The Associated Press/Washington Post reports on Republicans' "chilly reception Monday to President Barack Obama's invitation to discuss health care in a bipartisan, televised setting later this month, part of the White House effort to revive the stalled legislation."
Checking blood pressure at home gives better control
Researchers in Finland have found that self-monitoring of blood pressure at home leads to better control over high blood pressure than does standard monitoring at the doctor's office.
Encorium CRO acquires Progenitor
Encorium Group, Inc., a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced that it has acquired Progenitor Holdings AG, a corporation organized in Switzerland and its wholly-owned subsidiaries organized in Mexico, Panama, Argentina, Chile, Switzerland, India and Hong Kong for cash and stock valued at EURO 1.7 million, plus earn-out consideration of cash and stock with a value of up to EURO 1.5 million.
FDA approves Merit's phase 3 clinical trial protocol to treat primary liver cancer with QuadraSphere Microspheres
The Food and Drug Administration (FDA) has approved Merit Medical Systems, Inc.'s phase 3 clinical trial protocol to treat primary liver cancer with QuadraSphere™ Microspheres (hqTACE) for delivery of doxorubicin. The clinical trial will involve U.S. and international interventional radiologists who treat patients with localized, unresectable hepatocellular carcinoma (HCC), the most common form of liver cancer.
› Verified 1 days ago